Tomáš Kvasnička

Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure

Ivan Netuka, Tomáš Kvasnička, J Kvasnička et al. · The Journal of Heart and Lung Transplantation · 2016 · 136 citations · Full text

Heart Failure, Von Willebrand Factor, Cardiovascular Disease +9

Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission

Jan Vevera, Zdeněk Fišar, Tomáš Kvasnička et al. · Psychiatry Research · 2005 · 79 citations

Lipid Disorder, Cardiovascular Disease, Medicine +8

Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

J Kvasnička, J Marek, Tomáš Kvasnička et al. · Clinical Endocrinology · 2000 · 53 citations

28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study

Jan Ulrych, Tomáš Kvasnička, Vladimír Frýba et al. · BMC Surgery · 2016 · 41 citations · Full text

Detection of apoptotic cells and expression of Ki‐67 antigen, Bcl‐2, p⁵³ oncoproteins in human parathyroid adenoma

Wenliang Wang, Henry Johansson, Tomáš Kvasnička et al. · Apmis · 1996 · 40 citations